Bumper Offer - Urjas oil Just @ Rs. 1
A Ret 0.5% Cream, a prescription drug, is manufactured in various forms such as Cream. Pimples are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of A Ret 0.5% Cream. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of A Ret 0.5% Cream are Fluid retention. While these are the most often observed A Ret 0.5% Cream side effects, there are can be others also. These have been listed below. These side effects of A Ret 0.5% Cream are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, A Ret 0.5% Cream's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to A Ret 0.5% Cream's effects on the liver, heart and kidney, if any, have been listed below.
A Ret 0.5% Cream is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy, Eczema are examples of such conditions. The section on A Ret 0.5% Cream contraindications lists all such conditions.
Besides this, A Ret 0.5% Cream may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that A Ret 0.5% Cream is not safe while driving, and is is not addictive in nature.
A Ret 0.5% Cream is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when A Ret 0.5% Cream is used -
Severe
Moderate
Mild
Common
Is the use of A Ret 0.5% Cream safe for pregnant women?
A Ret can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking A Ret right away. Take your doctor's advice before taking it again.
Is the use of A Ret 0.5% Cream safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking A Ret. It should only be taken after medical advice.
What is the effect of A Ret 0.5% Cream on the Kidneys?
Information about safety of A Ret for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of A Ret 0.5% Cream on the Liver?
There may be an adverse effect on the liver after taking A Ret. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of A Ret 0.5% Cream on the Heart?
A Ret is not harmful for the heart.
A Ret 0.5% Cream should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take A Ret 0.5% Cream unless your doctor advises you to do so -
Is this A Ret 0.5% Cream habit forming or addictive?
No, there is no any evidence that A Ret 0.5% Cream is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking A Ret 0.5% Cream you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
A Ret 0.5% Cream is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of A Ret 0.5% Cream in mental disorders is not effective.
Interaction between Food and A Ret 0.5% Cream
It is safe to take A Ret 0.5% Cream with food.
Interaction between Alcohol and A Ret 0.5% Cream
Information about the interaction of A Ret 0.5% Cream and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)
